Working… Menu

An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02090959
Recruitment Status : Completed
First Posted : March 19, 2014
Last Update Posted : June 10, 2019
Information provided by (Responsible Party):
PTC Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 21, 2018
Actual Study Completion Date : June 21, 2018
Certification/Extension First Submitted : April 9, 2019